ENIMMUNE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.1 TWD | -0.69% |
|
+8.08% | -3.73% |
| 03-13 | Enimmune corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Enimmune corporation Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENIMMUNE CORPORATION | Bio Therapeutic Drugs | -0.69% | +8.08% | -3.73% | -31.37% | +48.93% | 73.54M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- 6564 Stock
- Charts Enimmune corporation
- Comparison Chart